An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C
Clinical trial NCT01889433 · COMPLETED
Trial details
- NCT number
- NCT01889433
- Sponsor
- Biocad
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-10
- Primary completion
- 2015-12-02
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.